96909 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
PLACENTA EXPRESSED PROTEINS FOR USE IN THE TREATMENT OF TENDON INJURY
#2D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#3Peptides for the Treatment of Retinitis Pigmentosa
#4LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE
#5Placental lipid bilayer for cell-free molecular interaction studies
#6PIF-TRANSFECTED CELLS AND METHODS OF USE
#7DRUG COMPLEXES COMPRISING ALPHA-FETOPROTEIN
#8Composition and system for separating and detecting alpha-fetoprotein variant and use thereof
#9DETECTION AND TREATMENT OF BREAST CANCER
#10PIF-TRANSFECTED CELLS AND METHODS OF USE
#11Alpha-fetoprotein “ring and tail” peptides
#12CHAPERONIN 10 VARIANTS
#13Formulation of Stable Recombinant Alpha-Fetoprotein Conjugated with Anti-Tumor Substance in Target-Delivery System for Treatment of Cancer and Autoimmune Disease
#14Pregnancy-associated plasma protein-A2 (PAPP-A2) polypeptides
#15Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein
#16Sperm-specific cation channel, Catsper2, and uses therefor
#17Modified chaperonin 10
#18ANTICANCER FUSION PROTEIN
#19Biological activity of placental protein 13
#20Angiogenesis-inhibiting peptide and application thereof
#21Pregnancy-associated plasma protein-A2 (PAPP-A2) polynucleotides
#22Alpha-fetoprotein “ring and tail” peptides
#23Chaperonin 10 variants
#24Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof
#25EXPRESSION OF SECRETED HUMAN ALPHA-FETOPROTEIN IN TRANSGENIC ANIMALS
#26Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#27USE OF INHIBITORS OF PLAC8 ACTIVITY FOR THE MODULATION OF ADIPOGENESIS
#28Modified chaperonin 10
#29NEW ASSAYS FOR PREIMPLANTATION FACTOR AND PREIMPLANTATION FACTOR PEPTIDES
#30ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF
#31METAL-BINDING COMPOUNDS AND USES THEREFOR
#32Metal-binding compounds and uses therefor
#33Metal-binding compounds and uses therefor
#34Marker for inflammatory conditions
#35Recombinant alpha-fetoprotein and compositions thereof
#36METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX
#37Modified Cpn10 and PRR signalling
#38EXPRESSION OF SECRETED HUMAN ALPHA-FETOPROTEIN IN TRANSGENIC ANIMALS
#39Selective exosite inhibition of PAPP-A activity against IGFBP-4
#40Marker for inflammatory conditions
#41Alpha-fetoprotein peptides and uses thereof
#42Metal-binding compounds and uses therefor
#43Assays for preimplantation factor and preimplantation factor peptides
#44METHOD OF DIAGNOSING PRE-ECLAMPSIA
#45Metal-binding compounds and uses therefor
#46Antibody to placental protein having a regulating action on proteolytic activity
#47Modified chaperonin 10
#48Recombinant alpha-fetoprotein and method of preparing
#49Alpha-fetoprotein peptides
#50Marker for inflammatory conditions
#51Inflammation-inhibitory serum factors and uses thereof
#52Sperm-specific cation channel, CATSPER2, and uses therefor
#53Marker for prolonged rupture of membranes
#54RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT
#55Alpha-fetoprotein peptides and uses for imaging
#56Assays for preimplantation factor and preimplantation factor peptides
#57Method for Isolating and Purifying Immuno-Modulating Polypeptide from Cow Placenta
#58Assays for preimplantation factor and preimplantation factor peptides
#59Assays for preimplantation factor and preimplantation factor peptides
#60Assays for preimplantation factor and preimplantation factor peptides
#61Assays for preimplantation factor and preimplantation factor peptides
#62Variants of alpha-fetoprotein coding and expression sequences
#63Alpha-fetoprotein peptides and uses thereof
#64Methods for early detection of pregnancy in cows
#65PIF tetrapeptides
#66USE OF PREGNANCY SPECIFIC GLYCOPROTEIN FOR MATURATION OF OOCYTES
#67Fusion proteins comprising alpha fetoprotein
#68Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
#69Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
#70Pregnancy-associated plasma protein-A2 (PAPP-A2)
#71Marker for inflammatory conditions
#72Method and compositions for treating hepatocellular cancer
#73Sequences used to identify if a female mammal comprises a mutation in the alpha-fetoprotein sequence(S) or a partial or total deletion of the alpha-fetoprotein sequence(S)
#74Alpha-fetoprotein peptides and uses thereof
#75EPF derived peptides and therapeutic compositions
#76Compositions and methods of using Alpha-fetoprotein growth inhibitory peptides
#77Marker for inflammatory conditions
#78Longevity and PAPP-A
#79Metal-binding compounds and uses therefor
#80Use of rAFP inhibit or prevent apoptosis
#81Marker for inflammatory conditions
#82PP14 fusion proteins and methods for making and using the same
#83Assays for preimplantation factor and preimplantation factor peptides
#84Transgenic mouse lacking PAPP-A activity
#85Recombinant human alpha-fetoprotein as an immunosuppressive agent